ScholarIQanswers from OpenAlex & ORCID
Steven D. Schwartz
ResearcherPublications, citations & collaboration network
Steven D. Schwartz is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Steven D. Schwartz have?
ScholarIQindexed works
Steven D. Schwartz has 367 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Steven D. Schwartz have?
ScholarIQcitation count
Steven D. Schwartz has 9,405 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Steven D. Schwartz?
ScholarIQh-index
Steven D. Schwartz has an h-index of 52 in OpenAlex.
What is the i10-index of Steven D. Schwartz?
ScholarIQi10-index
Steven D. Schwartz has an i10-index of 166 in OpenAlex.
What is the ORCID of Steven D. Schwartz?
ScholarIQorcid
The ORCID for Steven D. Schwartz is on the source record.
What is the OpenAlex record for Steven D. Schwartz?
ScholarIQopenalex
The OpenAlex for Steven D. Schwartz is on the source record.
What are the most-cited papers on Steven D. Schwartz?
ScholarIQmost cited works
A Phase II Randomized Double-Masked Trial of Pegaptanib, an Anti–Vascular Endothelial Growth Factor Aptamer, for Diabetic Macular Edema
Emmett T. Cunningham, Anthony P. Adamis, Michael M. Altaweel, Lloyd Paul Aiello, Neil M. Bressler, Donald J. D’Amico, Mauro Goldbaum, David R. Guyer, Barrett Katz, Manju Patel, Steven D. Schwartz
Theoretical Methods in Condensed Phase Chemistry
Steven D. Schwartz
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial
Arshad M. Khanani, Arshad M Khanani, Sunil S Patel, Giovanni Staurenghi, Ramin Tadayoni, Carl J Danzig, David A Eichenbaum, Jason Hsu, Charles C Wykoff, Jeffrey S Heier, David R Lally, Jordi Monés, Jared S Nielsen, Veeral S Sheth, Peter K. Kaiser, Julie Clark, Liansheng Zhu, Hersh Patel, Justin Tang, Dhaval Desai, Glenn J. Jaffe, Arturo Alezzandrini, A Francone, Joaquín Bafalluy, Silvina Bainttein, Jose Luna Pinto, Mario Saravia, Matko Vidosevich, Carlos Zeolite, Federico Furno Sola, Andrew Chang, Elisa E. Cornish, Thanh N. Nguyen, Oliver Findl, Anton Haas, Martina Kralinger, Stefan Sacu, Laurence Postelmans, Michel Eid Farah, Maurício Maia, Márcio Bittar Nehemy, Fareed Ali, Michael H. Brent, Michael Dollin, John R. Gonder, Amin Kherani, Andrew Merkur, Raman Tuli, Monica Marie Lopera, Francisco J. Rodríguez, Mario Bradvica, Jan Ernest, Kuldar Kalijurand, Kai Noor, Yves Cohen, Catherine Creuzot‐Garcher, F. De Bats, François Devin, Catherine Français-Maury, Laurent Kodjikian, Jean François Korobelnik, Y. Le Mer, M. Quaranta El Maftouhi, Sam Razavi, Eric H. Souied, Ramin Tadayoni, Michel Weber, Nicole Eter, Nicolas Feltgen, Salvatore Grisanti, Peter Walter, Raffael Liegl, Katrin Lorenz, Georg Spital, Siegfried Priglinger, Martin S. Spitzer, Michael Völker, Tim U. Krohne, Claudia Jochmann, Chris P. Lohmann, Carsten Framme, Ágnes Kerényi, András Papp, András Seres, Edit Tóth‐Molnár, Alexis Tsorbatzoglou, A VAJAS, Balázs Varsányi, Gábor Vogt, Asaf Bar, Eva Eting, David Hauser, Jamie Levy, Nurit Mathalone, Haia Morori-Katz, Irit Rosenblatt, Shiri Soudry-Zayit, Omert Trivizky, Francesco Bandello, Antonio P. Ciardella
Enzymatic transition states and dynamic motion in barrier crossing
Steven D. Schwartz, Vern L. Schramm
Maximum Tolerated Dose of a Humanized Anti–Vascular Endothelial Growth Factor Antibody Fragment for Treating Neovascular Age-Related Macular Degeneration
Philip J. Rosenfeld, Steven D. Schwartz, Mark S. Blumenkranz, Joan W. Miller, Julia A. Haller, James D. Reimann, William H. Greene, N. Shams